Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 9, 2008

View Archived Issues

Targeting NR2 NMDA receptor subunit useful in early experimental parkinsonism

Suven's new 5-HT6 antagonist shows preclinical efficacy in obesity

Snapshots on T-type calcium channel antagonists discovered at Merck & Co.

Magic Factor-1: A hepatocyte growth factor-derived partial Met agonist to counter muscle wasting

BTG acquires Protherics

Symphogen and Meiji achieve milestone in polyclonal antibody collaboration

Anika completes enrollment in clinical trial of Monovisc for knee pain in osteoarthritis

European Commission approves Roche's Pegasys plus Copegus for hepatitis C

PharmaMar submits registration dossier to EMEA for Yondelis in relapsed ovarian cancer

FDA grants orphan drug designation to Genta's tesetaxel for advanced melanoma

BioSante and Azur sign marketing agreement for Elestrin for hot flashes in menopausal women

Gilead initiates phase I clinical trial to evaluate safety and tolerability of GS-9411

Novel therapeutic agents for cardiovascular disorders reported in recent patent literature

rBCG(mbtB)30 vaccine: A novel approach for tuberculosis in patients with HIV

Recent Takeda patent describes new agents for sleep disorders

Osiris presents update on the clinical development of Prochymal for GVHD

Kiadis reports phase I/II clinical trial results of ATIR in mismatched bone marrow transplant

Lentigen and PATH enter partnership for H5N1 VLP prototype pandemic influenza vaccine

OPKO completes enrollment in phase III clinical trial of bevasiranib in wet AMD

Silence Therapeutics to submit CTA for Atu-027 in December 2008

Acrux submits Ellavie MAA in Sweden for treating menopause symptoms

FDA Advisory Committee recommends approval of Latisse for hypotrichosis

Recent patents disclose new treatments for asthma and other respiratory disorders

Pilot study shows potential of ON-1910Na in myelodysplastic syndromes

Azacitidine investigated in AML, MDS after hematopoietic stem cell transplantation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...